<DOC>
	<DOCNO>NCT00303017</DOCNO>
	<brief_summary>safety , efficacy acceptability Flavocoxid</brief_summary>
	<brief_title>Safety , Efficacy Acceptability Flavocoxid ( Limbrel ) A Pilot Study</brief_title>
	<detailed_description>Safety , Efficacy acceptability Flavocoxid ( Limbrel ) compare Naproxen Subjects Osteoarthritis Knee . A Pilot Study</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>OA knee , KL grade 23 general good health currently take NSAID COX2 inhibitor pregant nursing woman grade 1 4 OA significant medical condition opinion physician might put subject risk study form arthropathy OA condition might confound evaluation pain , stiffness function target joint intraarticular cotticosteroid inkection target joint within 3 month screen visit concomitant use antiinflammatory anti arthritic medication product ( include OTC herbal preparation ) Low dose aspirin cardioprotection allow concomitant use coumadin anticoagulant antiplatelet medication concomitant use gastroprotectiv medication include , limited , H2 blockers proton pump inhibitor , include OTC herbal product History allergy Flavonoids</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>